USFDA red flags Lupin for significant violations at MP unit
Posted by
www.biotecnika.org
The USFDA said it had inspected the Unit 1 at the Mandideep facility
of the company from November 26 to December 4, 2018.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-red-flags-lupin-for-significant-violations-at-mp-unit/articleshow/71441872.cms
Subscribe to:
Post Comments (Atom)
Post a Comment